BIOHIT OYJ SER'B'EUR0.17BB

BIOHIT OYJ SER'B'EUR0.17

2.96EURD
+0.01+0.34%
At close at Mar 7, 14:49 GMT
EUR
No trades
See on Supercharts

0DRP fundamentals

Key facts

Market capitalization‪44.79 M‬EUR
Founded1988
CEOJussi Hahtela
About

Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. It also offers acetaldehyde binding products, monoclonal antibodies, and instruments. The company was founded by Osmo Suovaniemi in 1988 and is headquartered in Helsinki, Finland.

Ownership
‪‪12.21 M‬‬
Closely held shares
‪‪7.46 M‬‬ (61.12%)
Free Float shares
‪‪4.75 M‬‬ (38.88%)
Closely held shares
‪‪7.46 M‬‬ (61.12%)
Free Float shares
‪‪4.75 M‬‬ (38.88%)
Capital structure
Market cap
‪‪44.79 M‬‬
Debt
‪‪600.00 K‬‬
Cash & equivalents
‪‪6.70 M‬‬
Enterprise value
‪‪38.69 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪44.79 M‬‬
Price to earning ratio (P/E)
17.89x
Price to sales ratio (P/S)
3.13x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
17.89x
Price to sales ratio (P/S)
3.13x
Valuation ratios
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪10.00‬
‪20.00‬
‪30.00‬
‪40.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−8%‬
‪0%‬
‪8%‬
‪16%‬
‪24%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−2.50 M‬‬
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
‪‪7.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪2.00 M‬‬
‪‪4.00 M‬‬
‪‪6.00 M‬‬
‪‪8.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪2.00 M‬‬
‪‪4.00 M‬‬
‪‪6.00 M‬‬
‪‪8.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Diagnostic Tests, Analysis Systems, and Products
By country
Period: 2024
Europe, Other
Asia
Other Countries
North and South America
Finland

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
‪0.00‬
‪‪2.10 M‬‬
‪‪4.20 M‬‬
‪‪6.30 M‬‬
‪‪8.40 M‬‬
Actual
Estimate
Earnings
Next:Aug 6, 2025
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
‪0.00‬
‪0.03‬
‪0.05‬
‪0.08‬
‪0.10‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

0DRP does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−1.70 M‬‬
‪0.00‬
‪‪1.70 M‬‬
‪‪3.40 M‬‬
‪‪5.10 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪3.00 M‬‬
‪‪6.00 M‬‬
‪‪9.00 M‬‬
‪‪12.00 M‬‬
Assets
Liabilities